Revvity stock price target lowered to $115 by Bernstein on China headwinds

Published 29/07/2025, 13:06
Revvity stock price target lowered to $115 by Bernstein on China headwinds

Investing.com - Bernstein SocGen Group lowered its price target on Revvity Inc (NYSE:RVTY) to $115.00 from $120.00 on Tuesday, while maintaining a Market Perform rating on the stock. According to InvestingPro data, the company maintains strong fundamentals with a perfect Piotroski Score of 9, indicating robust financial health.

The price target reduction follows Revvity’s second-quarter 2025 results released on Monday, which showed organic growth of 3% matching consensus estimates, while earnings per share of $1.18 exceeded analyst expectations of $1.14 by 3.5%.

Despite meeting quarterly expectations, Revvity reduced its full-year guidance, now projecting organic revenue growth of 2%-4%, earnings per share of $4.85-$4.95, and operating margin of 27.1%-27.3%.

The company’s stock fell approximately 8% after the announcement, primarily due to new pressure on Revvity’s immunodiagnostics business in China, which represents about 6% of the company’s revenue.

Bernstein noted that while Revvity’s year-to-date performance now aligns more closely with industry peers, the firm continues to see limited catalysts for additional value creation, citing muted sales in academic, government, and pharmaceutical instruments sectors, along with continued challenges in the Chinese immunodiagnostics market for several quarters ahead.

In other recent news, Revvity Inc. reported its second-quarter 2025 earnings, surpassing analyst expectations. The company achieved an adjusted earnings per share of $1.18, outperforming the forecasted $1.14. Additionally, Revvity’s revenue reached $720 million, exceeding the anticipated $710.39 million. Despite this positive earnings report, Jefferies recently lowered its price target for Revvity to $100 from $106, while maintaining a Hold rating. This adjustment was influenced by Revvity’s guidance related to China’s drug-related group policies, which are expected to impact the company’s financial outlook. These developments highlight the mixed reactions from analysts and investors regarding Revvity’s recent performance and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.